The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

Status:	Recruiting
Conditions:	Neurology, Neurology, Multiple Sclerosis
Therapuetic Areas:	Neurology, Other
Healthy:	No
Age Range:	18 - Any
Updated:	4/6/2019
Start Date:	July 1, 2017
End Date:	December 31, 2021
Contact:	Amy E Hall, MS
Email:	amy.e.hall@hitchcock.org
Phone:	603-653-6871

Improving Quality and Value of Multiple Sclerosis Care at the Microsystem Level: The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

To establish the first systems level continuous quality improvement (CQI) collaborative for
multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and
assessments of geographic variation in MS care quality and value, and study the effect of CQI
interventions on improvement of selected performance (quality) indicators.

This is a three year study which will employ a step-wedge randomized design which will expose
three of four participating centers to a healthcare QI intervention during the 3 year period.
Each of the centers exposed to an intervention will serve as its own control during a
baseline pre-intervention period during the first year of the study. The fourth site will
serve as a longitudinal control for comparison to the other three centers exposed to a QI
intervention.

Inclusion Criteria:

- Adults aged 18 years or older with documented clinically confirmed MS who are followed
by one of the participating MS centers.

Exclusion Criteria:

- Candidates will be excluded from study entry if they are unable or unwilling to
provide informed consent.

We found this trial at

sites

Massachusetts General Hospital Multiple Sclerosis Center

Boston, Massachusetts 02114

Principal Investigator: Eric Klawiter, MD

Phone: 617-724-3133

from

Boston, MA